Cirrus Therapeutics, Inc.

Cambridge, MA · Founded 2022 · CIK 0002078601 · Biotech · Private

Therapies for age-related macular degeneration (AMD)

cirrustx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$6.7M
1 Form D · Aug 2025
14 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$6,698,321
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2492Cerevel Therapeutics——
2493BIOMARCK PHARMACEUTICALS, LTD—$8.0M
2494AMYGDALA NEUROSCIENCES, INC.—$7.0M
2495Cirrus Therapeutics, Inc.—$6.7M
2496Semnur Pharmaceuticals, Inc.—$6.0M
2497b3 bio, inc.—$5.7M
2498DUET BIOSYSTEMS, INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Alexandra CantleyDirector
  • Ying Kai ChanDirector · Executive Officer · Promoter
  • Andrew DickDirector · Promoter
  • Khoo ShihDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.